The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …

The SARS-CoV-2 Omicron BA.1 variant emerged in 2021 1 and has multiple mutations in its
spike protein 2 . Here we show that the spike protein of Omicron has a higher affinity for …

A single antibody was shown to adopt different binding-site conformations and thereby bind
unrelated antigens. Analysis by both x-ray crystallography and pre–steady-state kinetics …

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) virus, leads to respiratory symptoms that can be fatal. However, …

Complex organisms have evolved from a limited number of primordial genes and proteins.
However, the mechanisms by which the earliest proteins evolved and then served as the …

Antibodies provide effective antiviral immunity despite the fact that viruses escape into cells
when they infect. Here we show that antibodies remain attached to viruses after cell infection …

Human immunodeficiency virus (HIV)-1 is able to replicate in primary human macrophages
without stimulating innate immunity despite reverse transcription of genomic RNA into double…

Lentiviruses such as HIV-1 traverse nuclear pore complexes (NPC) and infect terminally
differentiated non-dividing cells, but how they do this is unclear. The cytoplasmic NPC protein …

Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infects cells by binding to
the host cell receptor ACE2 and undergoing virus-host membrane fusion. Fusion is …

The spike (S) protein of SARS-CoV-2 mediates receptor binding and cell entry and is the
dominant target of the immune system. It exhibits substantial conformational flexibility. It …